Biosortia Pharmaceuticals

Biosortia Pharmaceuticals is a drug discovery and development company with a focus on accessing novel chemistry from microorganisms found in aquatic microbiomes. The company utilizes a proprietary technology to obtain and study these microorganisms, many of which are difficult to cultivate using traditional methods. This allows them to explore a new range of small molecules for potential therapeutic applications.

The company's primary therapeutic areas of interest are immuno-oncology and immunology. By identifying and developing new drug candidates from these previously untapped natural sources, Biosortia aims to provide new options for treating a variety of diseases. Their business model involves forming strategic partnerships with other pharmaceutical companies to further develop and commercialize the drug candidates they discover.

Biosortia operates in the biotechnology and pharmaceutical sectors, serving as a source of new drug leads for the broader pharmaceutical industry. The company's approach of mining the microbiome for new chemical entities positions it at the intersection of biotechnology, drug discovery, and natural product chemistry.

Keywords: drug discovery, microbiome, immuno-oncology, immunology, small molecules, aquatic microorganisms, therapeutics, biotechnology, pharmaceutical, drug development